PMC:4913875 / 19668-20794 JSONTXT

{"project":"testtesttest","denotations":[{"id":"T118","span":{"begin":270,"end":282},"obj":"Body_part"},{"id":"T119","span":{"begin":384,"end":389},"obj":"Body_part"},{"id":"T120","span":{"begin":390,"end":397},"obj":"Body_part"},{"id":"T121","span":{"begin":492,"end":499},"obj":"Body_part"},{"id":"T122","span":{"begin":761,"end":768},"obj":"Body_part"},{"id":"T123","span":{"begin":802,"end":809},"obj":"Body_part"}],"attributes":[{"id":"A118","pred":"uberon_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/UBERON_0002416"},{"id":"A119","pred":"uberon_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/UBERON_0003978"},{"id":"A120","pred":"uberon_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/UBERON_3010058"},{"id":"A121","pred":"uberon_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/UBERON_3010058"},{"id":"A122","pred":"uberon_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/UBERON_3010058"},{"id":"A123","pred":"uberon_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/UBERON_3010058"}],"text":"The first subgroup includes the patients with the smallest grafts of our study with diameters of 10, 11, 12 and 14 mm implanted at the respective ages of 0.2, 0.8, 2.9 and 1.7 years. In all 4 patients, after a follow-up of 4.5, 1.8, 2.9 and 2.6 years and an increase of body surface area from 0.25–0.55, 0.35–0.4, 0.52–0.63 and 0.5–0.62 m2, respectively, no corresponding increase in valve annulus diameter could be observed so far (Fig. 4, black lines).\nFigure 4: z-Value development of DAH annulus size for subgroups over time. Black lines delineate patients younger than 10 years with a DAH smaller than 15 mm at implantation, green—patients younger than 10 years with a DAH bigger than 15 mm and red—patients older than 10 years. z-Value development of DAH annulus size over time. Package labelled annulus diameter was rounded to z-value integers, and each postoperative measurement is again expressed as a z-value according to the actual height and weight of the patient. A loess fit curve was then drawn for each implant size group. The green area shows the normal range in the middle of which the lines should converge."}